Marty Makary

Dr. Marty Makary, the new head of the FDA and a former professor and surgeon, discusses his ambitious plans to reform the agency. He highlights how the FDA has been influenced by Big Food and Big Pharma. Key topics include the rise of ultra-processed foods linked to childhood obesity, the need for clearer vaccine regulations amidst rising measles cases, and the integration of AI in speeding up drug approvals. Makary emphasizes a transparent approach to rebuild trust in public health initiatives.

Dr. Marty Makary, the new FDA Commissioner, discusses his fresh insights just weeks into his role. He highlights the need to reform FDA practices amidst concerns about corruption and Big Pharma. The conversation dives into the alarming rise of chronic diseases and autism, promoting a holistic understanding of health through nutrition. Makary emphasizes transparency in drug approvals and the importance of trust post-COVID. He also shares exciting collaborations and innovative health strategies, blending humor with serious public health reform.

Marty Makary, a prominent physician and FDA Commissioner, dives into critical public health issues. He discusses the risks of Tylenol during pregnancy and its links to autism concerns, urging caution. Makary also critiques vaccine safety, addressing myocarditis and misinformation. He sheds light on Anthony Fauci’s approach to COVID-19, emphasizing the consequences of transparency failures. Furthermore, he highlights the urgent need for reforms in food policy and drug pricing, advocating for a healthier society and better healthcare access.

Dr. Marty Makary, a renowned surgeon and public health researcher, challenges the narrative surrounding COVID-19, claiming Fauci concealed crucial information and discussing the FDA's mishandling of vaccine risks. He highlights the rising health issues in children linked to diet and advocates for major reforms in the food system. Makary also raises concerns about pediatric transgender treatments, emphasizing the need for evidence-based approaches. His insights on restoring trust in healthcare and revamping drug approval processes paint a bold picture for future public health.

Dr. Marty Makary, FDA Commissioner and health policy professor at Johns Hopkins, brings a wealth of knowledge on women’s health. He discusses the transformative benefits of Hormone Replacement Therapy (HRT) for heart health and cognitive function, debunking long-standing myths from a flawed study. The conversation also reveals alarming risks associated with using antidepressants during pregnancy, and the impact of misinformation on public trust in health regulations. Makary advocates for transparency and accountability in medical practices, especially post-COVID.

Marty Makary, a physician and public-health expert, delves into the controversial link between prenatal acetaminophen and rising autism rates. He advocates for regulatory transparency and parents questioning vaccine timing. Meanwhile, Brandon Tatum, a former police officer and conservative commentator, analyzes the recent Charlie Kirk memorial and confronts Antifa tactics on campus, highlighting the challenges of law enforcement. Together, they explore themes of national sovereignty, media bias, and the shifting landscape of public health discussions.

Dr. Marty Makary, FDA Commissioner, advocates for modernizing drug safety and efficacy while tackling corruption in government. He highlights the need for transparency in drug approvals and critiques the impact of pharmaceutical advertising. The discussion delves into the influence of ultra-processed foods on children's health and stresses the importance of holistic nutrition. With insights into accountability and the opioid crisis, Dr. Makary calls for a significant reform in health policies and education to enhance public health outcomes.

Dr. Marty Makary, the newly confirmed FDA Commissioner, brings his expertise as a surgical oncologist and bestselling author into a powerful conversation about the agency's inner workings. He reveals alarming insights on conflicts of interest, the suppression of dissent, and the urgent need for reforms in food and drug regulation. Marty also tackles controversial topics like Tylenol in pregnancy and hormone therapy myths while promoting transparency and patient choice. His candid perspectives on tackling big food impacts and lowering drug prices could reshape public health.

Chris Hughes, co-founder of Facebook and co-chair of the Economic Security Project, critiques the Trump administration's approach to industrial policy, highlighting the need for a clearer strategy. Meanwhile, Dr. Marty Makary, FDA Commissioner, discusses the groundbreaking removal of black box warnings for hormone replacement therapy, emphasizing its benefits for women’s health, including reduced heart disease risk. He also addresses the historical context of hormone therapy and the importance of informed decision-making for women.

Russell Vought, Director of the Office of Management and Budget, shares insights on government spending and the Federal Reserve's monetary policies. Marty Makary, the new FDA Commissioner, discusses the challenges of restoring public trust in health agencies amid vaccine hesitancy and the ongoing impacts of COVID-19. The guests tackle the rising pressure on economic policies, including President Trump's tariffs on Canada and the audit of the Fed's strategic decisions. Their candid conversation highlights the intersection of healthcare and economics in shaping public perception and policy.